Overview

Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne

Status:
Recruiting
Trial end date:
2022-03-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess preliminary efficacy and safety of LYS006 in patients with moderate to severe inflammatory acne and to determine if LYS006 has an adequate clinical profile for further clinical development.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals